» Articles » PMID: 36810868

A Hyperaldosteronism Subtypes Predictive Model Using Ensemble Learning

Abstract

This study aimed to develop a machine-learning algorithm to diagnose aldosterone-producing adenoma (APA) for predicting APA probabilities. A retrospective cross-sectional analysis of the Japan Rare/Intractable Adrenal Diseases Study dataset was performed using the nationwide PA registry in Japan comprised of 41 centers. Patients treated between January 2006 and December 2019 were included. Forty-six features at screening and 13 features at confirmatory test were used for model development to calculate APA probability. Seven machine-learning programs were combined to develop the ensemble-learning model (ELM), which was externally validated. The strongest predictive factors for APA were serum potassium (s-K) at first visit, s-K after medication, plasma aldosterone concentration, aldosterone-to-renin ratio, and potassium supplementation dose. The average performance of the screening model had an AUC of 0.899; the confirmatory test model had an AUC of 0.913. In the external validation, the AUC was 0.964 in the screening model using an APA probability of 0.17. The clinical findings at screening predicted the diagnosis of APA with high accuracy. This novel algorithm can support the PA practice in primary care settings and prevent potentially curable APA patients from falling outside the PA diagnostic flowchart.

Citing Articles

Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism.

Vekony B, Nyiro G, Herold Z, Fekete J, Ceccato F, Gruber S Hypertension. 2024; 81(12):2479-2488.

PMID: 39417220 PMC: 11578053. DOI: 10.1161/HYPERTENSIONAHA.124.23418.


Prediction and causal inference of cardiovascular and cerebrovascular diseases based on lifestyle questionnaires.

Nambo R, Karashima S, Mizoguchi R, Konishi S, Hashimoto A, Aono D Sci Rep. 2024; 14(1):10492.

PMID: 38714730 PMC: 11076536. DOI: 10.1038/s41598-024-61047-w.


A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling.

Aiga K, Kometani M, Karashima S, Konishi S, Higashitani T, Aono D Sci Rep. 2023; 13(1):22429.

PMID: 38104216 PMC: 10725449. DOI: 10.1038/s41598-023-49808-5.


O tempora, o mores: The Age We Live In, Machine Learning, Hypertension, and Primary Aldosteronism.

Stratakis C JACC Asia. 2023; 3(4):676-677.

PMID: 37614549 PMC: 10442877. DOI: 10.1016/j.jacasi.2023.06.005.


Recent progress in the diagnosis and treatment of primary aldosteronism.

Yoshida Y, Shibata H Hypertens Res. 2023; 46(7):1738-1744.

PMID: 37198444 DOI: 10.1038/s41440-023-01288-w.

References
1.
Kayser S, Dekkers T, Groenewoud H, van der Wilt G, Carel Bakx J, van der Wel M . Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016; 101(7):2826-35. DOI: 10.1210/jc.2016-1472. View

2.
Abraham A, Pedregosa F, Eickenberg M, Gervais P, Mueller A, Kossaifi J . Machine learning for neuroimaging with scikit-learn. Front Neuroinform. 2014; 8:14. PMC: 3930868. DOI: 10.3389/fninf.2014.00014. View

3.
Waljee A, Mukherjee A, Singal A, Zhang Y, Warren J, Balis U . Comparison of imputation methods for missing laboratory data in medicine. BMJ Open. 2013; 3(8). PMC: 3733317. DOI: 10.1136/bmjopen-2013-002847. View

4.
Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H . Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab. 1990; 71(4):825-30. DOI: 10.1210/jcem-71-4-825. View

5.
Abe T, Naruse M, Young Jr W, Kobashi N, Doi Y, Izawa A . A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism. J Clin Endocrinol Metab. 2016; 101(3):1008-15. DOI: 10.1210/jc.2015-3431. View